AU2013365769B2 - Antimicrobial compounds, their synthesis and applications thereof - Google Patents
Antimicrobial compounds, their synthesis and applications thereof Download PDFInfo
- Publication number
- AU2013365769B2 AU2013365769B2 AU2013365769A AU2013365769A AU2013365769B2 AU 2013365769 B2 AU2013365769 B2 AU 2013365769B2 AU 2013365769 A AU2013365769 A AU 2013365769A AU 2013365769 A AU2013365769 A AU 2013365769A AU 2013365769 B2 AU2013365769 B2 AU 2013365769B2
- Authority
- AU
- Australia
- Prior art keywords
- lys
- boc
- group
- compound
- str
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- GOVXKUCVZUROAN-UHFFFAOYSA-N CCc1c[nH]c2ccccc12 Chemical compound CCc1c[nH]c2ccccc12 GOVXKUCVZUROAN-UHFFFAOYSA-N 0.000 description 1
- NJQHZENQKNIRSY-UHFFFAOYSA-N CCc1c[nH]cn1 Chemical compound CCc1c[nH]cn1 NJQHZENQKNIRSY-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C231/00—Preparation of carboxylic acid amides
- C07C231/12—Preparation of carboxylic acid amides by reactions not involving the formation of carboxamide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicinal Preparation (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN5299CH2012 | 2012-12-18 | ||
| IN5299/CHE/2012 | 2012-12-18 | ||
| PCT/IB2013/061090 WO2014097178A1 (en) | 2012-12-18 | 2013-12-18 | Antimicrobial compounds, their synthesis and applications thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2013365769A1 AU2013365769A1 (en) | 2015-07-02 |
| AU2013365769B2 true AU2013365769B2 (en) | 2018-03-15 |
Family
ID=54148251
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2013365769A Ceased AU2013365769B2 (en) | 2012-12-18 | 2013-12-18 | Antimicrobial compounds, their synthesis and applications thereof |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US9783490B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2934563B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6533466B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104981249B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2013365769B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112015014391B1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2894202A1 (cg-RX-API-DMAC7.html) |
| HK (1) | HK1210437A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2014097178A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105566149B (zh) * | 2016-03-02 | 2017-05-24 | 郑州大学 | 具有抗菌活性的查尔酮阳离子抗菌肽模拟物及其制备方法 |
| CN106995384B (zh) * | 2017-04-21 | 2018-12-11 | 郑州大学 | 具有抗菌活性的二烷基阳离子两亲性抗菌肽模拟物及其制备方法 |
| CN120118207A (zh) | 2017-12-15 | 2025-06-10 | 丹娜-法伯癌症研究院有限公司 | 稳定肽-介导的靶向蛋白降解 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995017888A1 (en) * | 1993-12-30 | 1995-07-06 | Smithkline Beecham Corporation | Phenylmethyl hexanamides, and the use thereof |
| WO2007129952A1 (en) * | 2006-05-09 | 2007-11-15 | Neobiotics Ab | Novel peptide derivatives useful as antimicrobial agents for treating wounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH07501085A (ja) | 1992-09-03 | 1995-02-02 | ベーリンガー インゲルハイム コマンディトゲゼルシャフト | 新規なアミノ酸誘導体、その製造方法及びこれらの化合物を含む医薬組成物 |
| US5654451B1 (en) * | 1993-01-14 | 2000-02-22 | Magainin Pharma | Amino acids and peptides having modified c-terminals and modified n-terminals |
| US5663148A (en) | 1994-07-12 | 1997-09-02 | Abbott Laboratories | Anaphylatoxin receptor ligands containing lipophilic residues |
| US6071890A (en) * | 1994-12-09 | 2000-06-06 | Genzyme Corporation | Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy |
| AU697565B2 (en) | 1995-12-12 | 1998-10-08 | Taiho Pharmaceutical Co., Ltd. | Epoxysuccinamide derivative or salt thereof and medicine comprising the same |
| CA2217550A1 (en) * | 1996-10-22 | 1998-04-22 | F. Hoffmann-La Roche Ag | Cationic lipids for gene therapy |
| RU2200154C2 (ru) * | 1997-12-12 | 2003-03-10 | Дайичи Файн Кемикал Ко., Лтд. | Новые ингибиторы металлопротеиназ |
| AU2180201A (en) * | 1999-11-30 | 2001-06-12 | Aventis Pharma S.A. | Hydroxamic acid macrocyclic derivatives, preparation method and compositions containing same |
| JP2002161084A (ja) * | 2000-11-28 | 2002-06-04 | Sumitomo Pharmaceut Co Ltd | 複素環誘導体 |
| US7393836B2 (en) | 2004-07-06 | 2008-07-01 | Boehringer Ingelheim International Gmbh | D-xylopyranosyl-substituted phenyl derivatives, medicaments containing such compounds, their use and process for their manufacture |
| GB0512751D0 (en) * | 2005-06-22 | 2005-07-27 | Glaxo Group Ltd | New adjuvant |
| US20080118525A1 (en) * | 2006-10-04 | 2008-05-22 | Oreola Donini | Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| JP2010512417A (ja) * | 2006-12-11 | 2010-04-22 | ワイス エルエルシー | イオンチャネルモジュレータ− |
| CN102757477B (zh) * | 2011-04-27 | 2014-09-03 | 首都医科大学 | 烯丙基半胱氨酰氨基酸甲酯衍生物及其合成方法和应用 |
| DK2709619T3 (en) * | 2011-05-16 | 2018-01-15 | Cellceutix Corp | RELATIONSHIPS FOR USING THE TREATMENT OF MUCOSITIS |
-
2013
- 2013-12-18 CA CA2894202A patent/CA2894202A1/en not_active Abandoned
- 2013-12-18 HK HK15111327.4A patent/HK1210437A1/xx unknown
- 2013-12-18 US US14/652,714 patent/US9783490B2/en not_active Expired - Fee Related
- 2013-12-18 CN CN201380070984.4A patent/CN104981249B/zh not_active Expired - Fee Related
- 2013-12-18 EP EP13865950.3A patent/EP2934563B1/en active Active
- 2013-12-18 AU AU2013365769A patent/AU2013365769B2/en not_active Ceased
- 2013-12-18 JP JP2015548841A patent/JP6533466B2/ja not_active Expired - Fee Related
- 2013-12-18 WO PCT/IB2013/061090 patent/WO2014097178A1/en not_active Ceased
- 2013-12-18 BR BR112015014391-1A patent/BR112015014391B1/pt not_active IP Right Cessation
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995017888A1 (en) * | 1993-12-30 | 1995-07-06 | Smithkline Beecham Corporation | Phenylmethyl hexanamides, and the use thereof |
| WO2007129952A1 (en) * | 2006-05-09 | 2007-11-15 | Neobiotics Ab | Novel peptide derivatives useful as antimicrobial agents for treating wounds |
Non-Patent Citations (1)
| Title |
|---|
| SVENSON JOHAN ET AL, JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 50, no. 14, doi:10.1021/JM0703542, ISSN 0022-2623, (2007-07-12), pages 3334 - 3339, (2007-06-15) * |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2894202A1 (en) | 2014-06-26 |
| JP2016504330A (ja) | 2016-02-12 |
| WO2014097178A1 (en) | 2014-06-26 |
| BR112015014391A2 (pt) | 2017-07-11 |
| EP2934563A4 (en) | 2016-08-17 |
| US20150329478A1 (en) | 2015-11-19 |
| HK1210437A1 (en) | 2016-04-22 |
| US9783490B2 (en) | 2017-10-10 |
| CN104981249B (zh) | 2018-06-19 |
| EP2934563A1 (en) | 2015-10-28 |
| BR112015014391B1 (pt) | 2020-11-03 |
| EP2934563B1 (en) | 2020-07-08 |
| JP6533466B2 (ja) | 2019-06-19 |
| CN104981249A (zh) | 2015-10-14 |
| AU2013365769A1 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11325955B2 (en) | Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections | |
| EP2350116B1 (en) | Treatment of biofilms | |
| JP5524858B2 (ja) | 抗菌性化合物 | |
| CN104284664A (zh) | 广谱抗生素Arylomycin类似物 | |
| KR20120104986A (ko) | 의료용 펩티드 | |
| US20200071361A1 (en) | Engineered antimicrobial amphiphilic peptides and methods of use | |
| CN103209700A (zh) | 广谱抗生素Arylomycin类似物 | |
| WO1998022493A2 (en) | N-(ARYL/HETEROARYL) AMINO ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS COMPRISING SAME, AND METHODS FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS BY USE OF SUCH COMPOUNDS | |
| US8541365B2 (en) | Dendrimeric compounds comprising amino acids, hyperbranched core compound, process for preparation of dendrimeric compounds comprising amino acids and hyperbranched core compound, and use thereof | |
| AU2015279705A1 (en) | Acinetobacter lysins | |
| EP3765057A1 (en) | Treatment of implants with engineered antimicrobial amphiphilic peptides | |
| KR20170052613A (ko) | 효모/곰팡이에 의해 유발되는 감염을 치료하기 위한 시스테아민의 사용 | |
| EP2934563B1 (en) | Antimicrobial compounds, their synthesis and applications thereof | |
| WO2022173981A1 (en) | Intravenous administration of engineered antimicrobial amphiphilic peptides | |
| CN108078982A (zh) | 脯氨酸衍生物在制备β-内酰胺酶抑制剂中的用途 | |
| CN106083994A (zh) | 取代的噁唑烷酮水溶性衍生物及其应用 | |
| WO2020196315A1 (ja) | 細胞層透過促進剤、薬剤吸収補助用組成物、及び医薬組成物 | |
| Hachim et al. | Design, molecular docking, synthesis, and antimicrobial evaluation of new dipeptide derivatives of ceftizoxime sodium | |
| Behroz | Structure-activity relationship studies of albicidin’s C-terminal dipeptide and N-terminal cinnamoyl residue | |
| WO2025240758A1 (en) | Staphylococcus hominis daptide antibiotics, derivatives thereof, and methods of treatment | |
| JP2009502810A (ja) | 補体系と相互作用する抗微生物剤 | |
| EP3335720A1 (en) | C-di-gmp binding peptides | |
| Class et al. | Patent application title: DENDRIMERIC PEPTIDES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME Inventors: Neville R. Kallenbach (Philadelpha, PA, US) Filbert Totsingan (Brooklyn, NY, US) | |
| CN108084075A (zh) | 具有β-内酰胺酶抑制作用的脯氨酸衍生物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FGA | Letters patent sealed or granted (standard patent) | ||
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |